peprostat
Peptideexperimental
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Jul 1, 2014 (NCT02204930)
Timeline
Indications
Studied for
Mechanism of action
Chemistry & pharmacology
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Also known as
- peprostat
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03131336 | Phase 2 | Mar 31, 2017 | Haemostatix Ltd, University of Cambridge |
| NCT02204930 | Phase 1 | Jul 1, 2014 | Haemostatix Ltd, University of Adelaide |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Haemostatix Ltd | For profit | 2 | 2 | 2 | 2014 |
| University of Adelaide | Academic/Hospital | 1 | 0 | 1 | 2014 |
| University of Cambridge | Academic/Hospital | 1 | 0 | 1 | 2017 |
3 organizations
Page 1 / 1